Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 69.89M P/E - EPS this Y - Ern Qtrly Grth -
Income -26.83M Forward P/E - EPS next Y 28.60% 50D Avg Chg 17.00%
Sales 852k PEG - EPS past 5Y - 200D Avg Chg -5.00%
Dividend N/A Price/Book 5.13 EPS next 5Y - 52W High Chg -56.00%
Recommedations 2.00 Quick Ratio 5.00 Shares Outstanding 98.95M 52W Low Chg 53.00%
Insider Own 17.33% ROA -88.72% Shares Float 76.17M Beta 0.10
Inst Own 13.91% ROE -181.25% Shares Shorted/Prior 438.08K/383.55K Price 1.38
Gross Margin -87.21% Profit Margin - Avg. Volume 79,746 Target Price 2.00
Oper. Margin -3,198.83% Earnings Date - Volume 23,257 Change -1.43%
About Movano Inc.

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

Movano Inc. News
11/14/24 Movano Health Reports Q3 2024 Financial Results and Provides Business Update
11/07/24 Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
11/06/24 Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024
11/04/24 Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
11/04/24 Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
10/31/24 Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
10/30/24 Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
10/25/24 Movano Health Announces Reverse Stock Split
10/24/24 Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase
10/10/24 Movano Health Provides Update on FDA Review of EvieMED Ring
09/17/24 Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades
09/03/24 Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
08/17/24 Movano (NASDAQ:MOVE) Will Have To Spend Its Cash Wisely
08/14/24 Movano Health Reports Q2 2024 Financial Results and Provides Business Update
08/05/24 Movano Health Provides Progress Update on EvieMED Regulatory Filing
08/05/24 Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
06/28/24 Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
06/13/24 Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
06/10/24 MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
05/15/24 Movano Health Reports Q1 2024 Financial Results and Provides Business Update
MOVE Chatroom

User Image EvacNam Posted - 13 hours ago

$MOVE IP and cash on hand is enough to add at these ridiculous prices. FDA is all but a lock. Makes no sense. Added more.

User Image beaches911 Posted - 3 days ago

$MOVE Movano was broken by extremely bad management

User Image EvacNam Posted - 3 days ago

$MOVE From Fitt Insider “Healthcare is broken. But, from apps to wearables to at-home tests, a paradigm shift is underway. • The global fitness tracker market is expected to reach $163B by 2030. • 39% of US consumers own a smartwatch or fitness tracker. • Beyond step counts, next-gen devices track stress, sleep, glucose, and HRV.”

User Image Investor203 Posted - 3 days ago

$MOVE told you all. Management should be in jail. They might be working to start another scam company

User Image EvacNam Posted - 4 days ago

$MOVE My ChatGPT “advisor” 5. Movano (MOVE) • Assessment: Shore Up • Why: Movano’s potential in wearable medical tech could be a sleeper hit if they succeed in securing FDA approvals and building adoption. The product-market fit here could explode as healthcare continues shifting toward personalized solutions. • What I’d Do: Double down while it’s cheap, especially if I believe in the leadership team’s vision and the market potential.

User Image EvacNam Posted - 6 days ago

$MOVE Obvious disconnect in current price. Benchmark revised after earnings: Change in Earnings Forecast Rating: Speculative Buy Current Price $3.52 Price Target $30.00 52-Wk Range $3.01 - $14.70 Market Cap $23 Enterprise Value $7 Shares Outstanding 6.6 Avg Vol (000s) 23 Cash $17 Debt $0.1 Sector Weight Market Weight

User Image beaches911 Posted - 1 week ago

$MOVE 50k in sales do only 285 rings sold

User Image EvacNam Posted - 1 week ago

$MOVE Moonshot play with FDA clearance on the horizon. Timing will be everything.

User Image Torijo1978 Posted - 1 week ago

$FGF what did I tell you folks? When these reverse split stocks take back their return shares and force you to be short one share, buy it heavy and bank hard!!! The one share buys (covering one share) at market price force the price up massively. Follow me for more notifications of when this happens so you can get in early and ride the squeeze up. THIS IS HORRIBLY BAD BUSINESS BY THESE COMPANIES AND WE WILL CAPITALIZE ON IT. $MOVE $SPCB $MGRX $QNTM

User Image beaches911 Posted - 1 week ago

$MOVE Back to the normal downtrend, that started when it IPO'd

User Image EvacNam Posted - 2 weeks ago

$MOVE shored up and averaged down to get to this… get ready.

User Image DavidStetson Posted - 2 weeks ago

$MOVE Is shortie have fun yet?

User Image EvacNam Posted - 2 weeks ago

$MOVE FDA approval could be any day. IMO, their tier one med device partner buys them out probably for pennies on the dollar, but should give longs a nice exit. Shorts beware.

User Image DavidStetson Posted - 2 weeks ago

$MOVE Next stop $4+ shortie is gonna get squeezed

User Image beaches911 Posted - 2 weeks ago

$MOVE Yep downward pressure, it always goes down, my bet is that it will be around $1 again in 6 months, all they have done is give the stock further to fall, the management team in this company is simply a disaster and the share price reflects their progress.

User Image backjackreturnes1 Posted - 2 weeks ago

$MOVE building pressure

User Image Jad_Herring Posted - 2 weeks ago

$MOVE $LVRO MYNZ +10.91% PM LFG, unusually high volume activity last week, apx 30% more than average. 👇😘🚀 This stock may see the last time this price per share PT $5+ 🚀 HUGE PRs drop incoming before the Nov 13 meeting, so compliance is coming—no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead.

User Image bandido20 Posted - 2 weeks ago

$HRYU last week to made a move of 200%. Imo this is primed to make a higher move from here. This getting a lot of attention and expecting continuation of momentum on monday. $HOLO amazing yesterday, Will be the start of a big run … $MOVE very tiny float, needs more time. Once it starts van be huge

User Image jotu Posted - 2 weeks ago

$MOVE 90k views https://www.tiktok.com/@heididamelio/video/7431286594759396639?is_from_webapp=1&sender_device=pc&web_id=7432765506195244564

User Image johnkicklighter Posted - 2 weeks ago

What markets are most reflecting the anxiety of the impending US election? We are looking here at the medium-term implied volatility (generally 30 days) readings for SPX, Bitcoin, Gold, EURUSD, emerging markets and Treasuries. $MOVE suggests yields most amped at 12mth high:

User Image EvacNam Posted - 2 weeks ago

$MOVE Back to positives. None of the larger players on the consumer side or the media device side have rings that are FDA approved or have a patented open design. With this low market cap, it has to be attracting attention: https://insider.fitt.co/oura-acquires-movement-health-platform-sparta-science/

User Image Dr_Stoxx Posted - 2 weeks ago

$MOVE (the VIX for bonds) tends to be inversely correlated to stocks. There has been a decoupling recently so something has to give soon: either a crash in stocks...or a big squeeze in bonds. Keep an eye on it for clues:

User Image EvacNam Posted - 2 weeks ago

$AQMS watch out for a coordinated pump then short. Has been happening to a lot of these wounded microcaps that R/S. Look at another Liquid Venture company $MOVE, happened a few days ago and presented opportunities.

User Image EvacNam Posted - 2 weeks ago

$MOVE @DavidStetson I hope the predatory shorts lose bad on this one. The company was not in trouble and the FDA approval is all but a slam dunk. Yes, they have had their issues, but the product is strong and the B2B opportunities are real and the hey have the support of the tier 1 med device company. This is the first real chance to make money if you have some 💎 hands and patience.

User Image DavidStetson Posted - 2 weeks ago

$MOVE Congrats to the longs that put their BIG boy pants on!

User Image HoldTheseBagsforMe Posted - 2 weeks ago

$MOVE Scam

User Image DavidStetson Posted - 10/31/24

$MOVE Bought more today as low as $3.06 and as high as $3.31 Adversity creates opportunity. When good news comes there will be more forced buying. LONGS put your BIG BOY pants on and buy a few shares!!!

User Image SteelWheels Posted - 10/31/24

$MOVE Join TW Research for more great picks like this one !!!

User Image beaches911 Posted - 10/31/24

$MOVE hilarious, now they want to investigate why people are selling, it’s because not a single milestone has ever been met by the company

User Image abbottm15 Posted - 10/31/24

$MOVE last press release I saw like this was $UPXI before it went from $3 to $15

Analyst Ratings
Benchmark Speculative Buy Sep 4, 24
Benchmark Speculative Buy Jul 30, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Leabman Michael Aaron Chief Technology Off.. Chief Technology Officer Jun 13 Buy 1.00 25,000 25,000 53,457 06/15/23
Mastrototaro John Chief Executive Offi.. Chief Executive Officer Jun 13 Buy 1.00 20,000 20,000 103,142 06/15/23
FAIRBAIRN EMILY Director Director Jun 13 Buy 1.00 250,000 250,000 528,571 06/15/23
Cullinan Brian Director Director Jun 13 Buy 1.00 10,000 10,000 237,070 06/15/23
Caballero Ruben Director Director Feb 15 Buy 1.41 18,200 25,662 58,200 02/16/23
Mastrototaro John Chief Executive Offi.. Chief Executive Officer May 12 Option 0.54 10,000 5,400 76,000 05/16/22
FAIRBAIRN EMILY Director Director Nov 18 Buy 3.97 5,000 19,850 390,417 11/19/21
Mastrototaro John Chief Executive Offi.. Chief Executive Officer Nov 18 Buy 3.99 6,000 23,940 66,000 11/19/21